Barclays analyst Gena Wang maintained a Buy rating on Cellectis SA (CLLS – Research Report) today and set a price target of $5.00. The ...

T he Oklahoma City Thunder edged out the Boston Celtics 118–112 on Wednesday night in a thrilling potential preview of this ...

Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the last six months while the S&P 500 has gained 1.6%. The past decade has ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Vertex Pharmaceuticals has dominated the cystic fibrosis (CF) market and is now expanding into new, high-growth areas. The ...

Moto AI embraces Google’s artificial intelligence stack, which includes access to products such as the Gemini assistant, the Imagen photo-creation model, and Google Cloud Vertex. In its initial ...

Social media was on fire after Michigan State beat U of M after Tre Holloman defended the logo tradition from some Michigan ...

The new CEO has a proven track record, previously growing Horizon's revenue from $300 million to ... This means shares outstanding don’t decline that much and the difference in 2024 is only ...

2-Year U.S. Treasury Note Continuous Contract $103.484 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $107.781 0.055 0.05% 10-Year U.S. Treasury Note Continuous Contract $110.719 0.078 ...

Nvidia introduced and justified the term by pointing to the chip's hardware transform and lighting (T&L) unit ... Radeon had fixed-function pixel and vertex shaders that were not programmable.

Vertex Pharmaceuticals EVP Ourania Tatsis sold 3,242 shares worth $1.62 million under a pre-arranged plan. The sale, executed on March 10, 2025, priced each share at $499.99, with Tatsis still holding ...